Quince Therapeutics, Inc. (QNCX)
$33.48-1.33%Close
BUYRECOVERY · day 33
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $9M
- Avg volume
- 56.5K
- Beta
- 1.40
- P/E (TTM)
- -0.49
- Short % float
- 22.76%
- Days to cover
- 1.5
- SI change
- +12.0%
- 1W
- -1.88%
- 1M
- +87.46%
- 3M
- +52.18%
- YTD
- -94.42%
- vs SPY 1W
- -0.69%
- vs SPY 1M
- +84.14%
- vs SPY 3M
- +49.79%
- vs SPY YTD
- -106.17%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- IMCRBUYImmunocore Holdings plcRECOVERYQ 5$36.61-0.73%
- CERSBUYCerus CorporationCRISISQ 5$2.69-4.27%
- IMRNBUYImmuron LimitedRECOVERYQ 4$1.12+0.00%
- FBLGBUYFibroBiologics, Inc. Common StockRECOVERYQ -32$1.35-6.25%
- WHWKBUYWhitehawk Therapeutics IncRECOVERYQ -12$4.88+3.17%
- THTXBUYTheratechnologies Inc.BULLQ 10$3.39+0.00%
- SCNIBUYScinai Immunotherapeutics Ltd.RECOVERYQ -3$3.13-2.80%
- STROSELLSutro Biopharma, Inc.CRISISQ -6$20.49-2.61%
- ORGOSELLOrganogenesis Holdings Inc.CRISISQ 5$1.67-7.22%
- ABBVBUYAbbVie Inc.BULLQ 22$264.52-0.17%
- ENVBSELLEnveric Biosciences, Inc.CRISISQ -8$1.41-1.40%
- VNDABUYVanda Pharmaceuticals Inc.RECOVERYQ 13$5.33+0.95%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
